M Gerstenhauer
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 3
- HER2/EGFR in Cancer Research 2
- Cancer Cells and Metastasis 1
- Cancer Risks and Factors 1
- Peptidase Inhibition and Analysis 1
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Ferdinand Hofstädter (7 shared papers)Olaf Ortmann (4 shared papers)Monika Klinkhammer‐Schalke (4 shared papers)Florian Zeman (4 shared papers)Michael Koller (4 shared papers)EC Inwald (3 shared papers)R. Schiffner (3 shared papers)J. Schiffner‐Rohe (3 shared papers)
In The Last Decade
M Gerstenhauer
7 papers receiving 600 citations
M Gerstenhauer's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 189
- Oncology 179
- Dermatology 40
- Pathology and Forensic Medicine 55
- Complementary and Manual Therapy 6
Countries citing papers authored by M Gerstenhauer
This map shows the geographic impact of M Gerstenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Gerstenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Gerstenhauer more than expected).
Fields of papers citing papers by M Gerstenhauer
This network shows the impact of papers produced by M Gerstenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Gerstenhauer. The network helps show where M Gerstenhauer may publish in the future.
Co-authors
The 16 scholars most cited alongside M Gerstenhauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry Hit paper breakdown → | 2013 | 444 |
| 2 | 2003 | 53 | |
| 3 | 2015 | 50 | |
| 4 | 2014 | 28 | |
| 5 | 2001 | 22 | |
| 6 | Dead Sea treatment - principle for outpatient use in atopic dermatitis: safety and efficacy of synchronous balneophototherapy using narrowband UVB and bathing in Dead Sea salt solution. | 2003 | 13 |
| 7 | 2015 | 10 |
About M Gerstenhauer
M Gerstenhauer is a scholar working on Oncology, Cancer Research, Immunology, Pathology and Forensic Medicine and Complementary and Manual Therapy, having authored 7 papers that have together received 620 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Cells and Metastasis (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Cancer Risks and Factors (1 paper), Therapeutic Uses of Natural Elements (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Cancer Research (189 citations), Oncology (179 citations), Dermatology (40 citations), Pathology and Forensic Medicine (55 citations) and Complementary and Manual Therapy (6 citations). M Gerstenhauer has collaborated with scholars based in Germany, Austria and Ireland. Frequent co-authors include Ferdinand Hofstädter, Olaf Ortmann, Monika Klinkhammer‐Schalke, Florian Zeman, Michael Koller, EC Inwald, R. Schiffner, J. Schiffner‐Rohe, W. Stolz and M. Landthaler. Their work appears in journals such as British Journal of Dermatology, Breast Cancer Research and Treatment, BioMed Research International, Journal of Cancer Research and Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.